Comparison of the effectiveness of cyclophosphamide and rituximab treatment in patients with systemic sclerosis–related interstitial lung diseases: a retrospective, observational cohort study

被引：0
作者：
Deniz Demir Yılmaz
Sermin Borekci
Benan Musellim
机构：
[1] Istanbul University-Cerrahpasa,Department of Pulmonary Diseases, Cerrahpasa Medical Faculty
来源：
Clinical Rheumatology | 2021年 / 40卷
关键词：
Cyclophosphamide; Rituximab; Systemic sclerosis–related interstitial lung diseases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4071 / 4079
页数：8
相关论文
共 50 条
  • [31] Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
    van den Hombergh, W. M. T.
    Simons, S. O.
    Teesselink, E.
    Knaapen-Hans, H. K. A.
    van den Hoogen, F. H. J.
    Fransen, J.
    Vonk, M. C.
    CLINICAL RHEUMATOLOGY, 2018, 37 (10) : 2715 - 2722
  • [32] Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease
    Ebata, Satoshi
    Yoshizaki, Ayumi
    Fukasawa, Takemichi
    Miura, Shunsuke
    Takahashi, Takehiro
    Sumida, Hayakazu
    Asano, Yoshihide
    Sato, Shinichi
    JOURNAL OF DERMATOLOGY, 2019, 46 (11) : 1006 - 1013
  • [33] Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
    W. M. T. van den Hombergh
    S. O. Simons
    E. Teesselink
    H. K. A. Knaapen-Hans
    F. H. J. van den Hoogen
    J. Fransen
    M. C. Vonk
    Clinical Rheumatology, 2018, 37 : 2715 - 2722
  • [34] High-dose prednisolone and bolus cyclophosphamide in interstitial lung disease associated with systemic sclerosis: a prospective open study
    Wanchu, Ajay
    Suryanaryana, Bettadpura Shamanna
    Sharma, Shefali
    Sharma, Aman
    Bambery, Pradeep
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2009, 12 (03) : 239 - 242
  • [35] CYCLOPHOSPHAMIDE AND LOW-DOSE PREDNISONE THERAPY IN PATIENTS WITH SYSTEMIC-SCLEROSIS (SCLERODERMA) WITH INTERSTITIAL LUNG-DISEASE
    SILVER, RM
    WARRICK, JH
    KINSELLA, MB
    KINSELLA, MB
    STAUDT, LS
    BAUMANN, MH
    STRANGE, C
    JOURNAL OF RHEUMATOLOGY, 1993, 20 (05) : 838 - 844
  • [36] Tocilizumab plus Nintedanib for progressive interstitial lung disease in systemic sclerosis: a one-year observational study
    Panopoulos, Stylianos
    Tzilas, Vasilios
    Bournia, Vasiliki-Kalliopi
    Tektonidou, Maria G.
    Sfikakis, Petros P.
    RHEUMATOLOGY INTERNATIONAL, 2024, : 1959 - 1966
  • [37] Real-world clinical effectiveness of rituximab rescue therapy in patients with progressive rheumatoid arthritis-related interstitial lung disease
    Narvaez, Javier
    Robles-Perez, Alejandro
    Molina-Molina, Maria
    Vicens-Zygmunt, Vanesa
    Luburich, Patricio
    Anibal Yanez, Marcos
    Jose Alegre, Juan
    Nolla, Joan M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 902 - 910
  • [38] Systemic sclerosis: comparison of efficacy of oral cyclophosphamide and azathioprine on skin score and pulmonary involvement-a retrospective study
    Poormoghim, Hadi
    Rezaei, Nader
    Sheidaie, Zeinab
    Almasi, Ali Reza
    Moradi-Lakeh, Maziar
    Almasi, Simin
    Andalib, Elham
    RHEUMATOLOGY INTERNATIONAL, 2014, 34 (12) : 1691 - 1699
  • [39] Comparison of the Effects of Cyclophosphamide and Mycophenolate Mofetil Treatment Against Immunoglobulin G4-Related Disease: A Retrospective Cohort Study
    Luo, Xuan
    Peng, Yu
    Zhang, Panpan
    Li, Jieqiong
    Liu, Zheng
    Lu, Hui
    Zhang, Xuan
    Zeng, Xiaofeng
    Zhang, Fengchun
    Fei, Yunyun
    Zhang, Wen
    FRONTIERS IN MEDICINE, 2020, 7
  • [40] Efficacy of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease: a systematic review and meta-analysis
    Ma, Xinyu
    Tang, Rui
    Luo, Mei
    Zeng, Zhuotong
    Shi, Yaqian
    Tang, Bingsi
    Xiao, Rong
    CLINICAL RHEUMATOLOGY, 2021, 40 (08) : 3185 - 3193
12345